Purchase Order HHSN272201700814P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $12,928.46 on August 15, 2017, for RNA kits, beads, and processor equipment on a firm fixed price basis. Work is performed in Hamilton, Montana, with an ultimate completion date of September 1, 2017.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA, PCR, and plasmid kits valued at $13,517.30 on June 21, 2017, with ultimate completion on June 26, 2017. Place of performance is Hamilton, Montana. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA and DNA screening kits valued at $4,491.12 on August 24, 2017, with an ultimate completion date of August 31, 2017. The order carries firm fixed pricing and no set-aside designation. Place of performance is Valencia, California.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>

The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $5,947.89 on January 3, 2018, with ultimate completion on January 28, 2018. The order procures HOTSTARTAQ PLUS DNA Polymerase (5,000 units, catalog #203607) under firm fixed price terms. Place of performance is Valencia, California.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,348.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The service agreement, which does not have a set-aside designation, is for Qiagen's QIAGILLITY products and services. Qiagen is an experienced federal contractor, having provided a range of molecular diagnostics, biotechnology, and bioinformatics...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,044.72 firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The order is for 2 kits of HOTSTARTAQ DNA POLYMERASE (25000). There is no set-aside designation noted. Qiagen has provided a range of products and services to various federal agencies, including DNA/RNA extraction kits, next-generation sequencing,...